VRNA

VRNA

USD

Verona Pharma plc American Depositary Share

$106.910+0.060 (0.056%)

实时价格

Healthcare
生物技术
英国

价格图表

Loading Chart...

关键指标

市场指标
公司基本面
交易统计

市场指标

开盘价

$106.850

最高价

$106.910

最低价

$106.910

成交量

1.87M

公司基本面

市值

9.1B

所属行业

生物技术

国家/地区

United Kingdom

交易统计

平均成交量

1.69M

交易所

NGM

货币

USD

52周价格范围

最低价 $31.6当前价 $106.910最高价 $106.93

相关新闻

Analyst Upgrades

Cantor Fitzgerald Suspends Overweight Rating on Verona Pharma PLC ADR, Maintains $100 Price Target

Cantor Fitzgerald suspends Overweight rating on Verona Pharma PLC ADR and Maintains $100 price target

查看更多
Cantor Fitzgerald Suspends Overweight Rating on Verona Pharma PLC ADR, Maintains $100 Price Target
BusinessWire

Merck Completes Acquisition of Verona Pharma

Acquisition strengthens Merck's cardio-pulmonary portfolio with addition of Ohtuvayre® (ensifentrine), a first-in-class COPD maintenance treatment, that is expected to grow into the next decade Merck (NYSE:MRK),

查看更多
Merck Completes Acquisition of Verona Pharma
GlobeNewswire

Acquisition of Verona by MSD Approved by the High Court of Justice of England and Wales

LONDON and RALEIGH, N.C., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Verona Pharma plc (NASDAQ:VRNA) ("Verona Pharma"), a biopharmaceutical company focused on respiratory diseases, which entered into a definitive agreement on

查看更多
Acquisition of Verona by MSD Approved by the High Court of Justice of England and Wales
GlobeNewswire

Shareholders of Verona Pharma Approve Proposed Acquisition by Merck

LONDON, U.K., and RALEIGH, N.C., Sept. 24, 2025 (GLOBE NEWSWIRE) -- Verona Pharma plc (NASDAQ:VRNA) ("Verona Pharma"), a biopharmaceutical company focused on respiratory diseases, which entered into a definitive

查看更多
Shareholders of Verona Pharma Approve Proposed Acquisition by Merck